Eagle Pharmaceuticals inc (EGRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access EGRX quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Eagle Pharmaceuticals inc's financial stability and long-term positioning.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Assets
Cash & cash equivalent55.32
Cash & Short-term Investments55.00
Accounts receivable72.44
Inventories47.79
Prepaid Expense And Other Assets Current13.20
Total Current Assets188.75
Equipment/Property/Plant Net1.17
Goodwill net45.03
Intangible Assets118.33
Other Assets, Noncurrent27.00
Deferred Income Tax Assets Net27.15
Total Assets406.16
Liabilities
Accounts Payable, Current AC18.99
Accrued Liabilities And Other Liabilities85.84
Long-term Debt, Current Maturities LO6.25
Other Liabilities, Current0.00
Total Current Liabilities111.09
Long-term debt56.22
Total Long-term Debt56.22
Other liabilities, Noncurrent5.30
Total Liabilities172.60
Stockholders' Equity
Common Stock Value0.02
Treasury Stock Value-243.12
Additional Paid In Capital Common Stock366.27
Retained Earnings / Accumulated Deficit111.50
Other Equity-1.11
Common Stockholder's Equity233.56
Total Stockholder's Equity233.56
Liabilities & Stockholder's Equity406.16
4 historic quarters locked

Sign in to unlock the full Eagle Pharmaceuticals inc balance sheet history.

About Eagle Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000827871-23-000024

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License